The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oxycodone-Global Market Insights and Sales Trends 2024
Synopsis
The global Oxycodone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oxycodone in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Oxycodone market. Long Acting Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Short Acting Oxycodone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oxycodone market, driven by demand from China, the second largest economy with some signs of stabilising, the Oxycodone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxycodone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxycodone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxycodone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxycodone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxycodone covered in this report include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt and Mylan, etc.
The global Oxycodone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior
Global Oxycodone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxycodone market, Segment by Type:
Long Acting Oxycodone
Short Acting Oxycodone
Global Oxycodone market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Oxycodone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oxycodone in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Others,, are propelling Oxycodone market. Long Acting Oxycodone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Short Acting Oxycodone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Oxycodone market, driven by demand from China, the second largest economy with some signs of stabilising, the Oxycodone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oxycodone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oxycodone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oxycodone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oxycodone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oxycodone covered in this report include Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Mallinckrodt and Mylan, etc.
The global Oxycodone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnson
Sanofi
Pfizer
Purdue Pharma
Endo International
Teva Pharmaceuticals
Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
Mallinckrodt
Mylan
Sun Pharmaceutical (Chattem Chemicals)
Impax Laboratories
Indivior
Global Oxycodone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oxycodone market, Segment by Type:
Long Acting Oxycodone
Short Acting Oxycodone
Global Oxycodone market, by Application
Hospital Pharmacies
Retail Pharmacies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oxycodone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oxycodone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oxycodone Market Overview
1.1 Oxycodone Product Overview
1.2 Oxycodone Market Segment by Type
1.2.1 Long Acting Oxycodone
1.2.2 Short Acting Oxycodone
1.3 Global Oxycodone Market Size by Type
1.3.1 Global Oxycodone Market Size Overview by Type (2018-2029)
1.3.2 Global Oxycodone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oxycodone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oxycodone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oxycodone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oxycodone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oxycodone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oxycodone Sales Breakdown by Type (2018-2023)
2 Global Oxycodone Market Competition by Company
2.1 Global Top Players by Oxycodone Sales (2018-2023)
2.2 Global Top Players by Oxycodone Revenue (2018-2023)
2.3 Global Top Players by Oxycodone Price (2018-2023)
2.4 Global Top Manufacturers Oxycodone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oxycodone Market Competitive Situation and Trends
2.5.1 Oxycodone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oxycodone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxycodone as of 2022)
2.7 Date of Key Manufacturers Enter into Oxycodone Market
2.8 Key Manufacturers Oxycodone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oxycodone Status and Outlook by Region
3.1 Global Oxycodone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oxycodone Historic Market Size by Region
3.2.1 Global Oxycodone Sales in Volume by Region (2018-2023)
3.2.2 Global Oxycodone Sales in Value by Region (2018-2023)
3.2.3 Global Oxycodone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oxycodone Forecasted Market Size by Region
3.3.1 Global Oxycodone Sales in Volume by Region (2024-2029)
3.3.2 Global Oxycodone Sales in Value by Region (2024-2029)
3.3.3 Global Oxycodone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oxycodone by Application
4.1 Oxycodone Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Others
4.2 Global Oxycodone Market Size by Application
4.2.1 Global Oxycodone Market Size Overview by Application (2018-2029)
4.2.2 Global Oxycodone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oxycodone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oxycodone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oxycodone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oxycodone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oxycodone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oxycodone Sales Breakdown by Application (2018-2023)
5 North America Oxycodone by Country
5.1 North America Oxycodone Historic Market Size by Country
5.1.1 North America Oxycodone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oxycodone Sales in Volume by Country (2018-2023)
5.1.3 North America Oxycodone Sales in Value by Country (2018-2023)
5.2 North America Oxycodone Forecasted Market Size by Country
5.2.1 North America Oxycodone Sales in Volume by Country (2024-2029)
5.2.2 North America Oxycodone Sales in Value by Country (2024-2029)
6 Europe Oxycodone by Country
6.1 Europe Oxycodone Historic Market Size by Country
6.1.1 Europe Oxycodone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oxycodone Sales in Volume by Country (2018-2023)
6.1.3 Europe Oxycodone Sales in Value by Country (2018-2023)
6.2 Europe Oxycodone Forecasted Market Size by Country
6.2.1 Europe Oxycodone Sales in Volume by Country (2024-2029)
6.2.2 Europe Oxycodone Sales in Value by Country (2024-2029)
7 Asia-Pacific Oxycodone by Region
7.1 Asia-Pacific Oxycodone Historic Market Size by Region
7.1.1 Asia-Pacific Oxycodone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oxycodone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oxycodone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oxycodone Forecasted Market Size by Region
7.2.1 Asia-Pacific Oxycodone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oxycodone Sales in Value by Region (2024-2029)
8 Latin America Oxycodone by Country
8.1 Latin America Oxycodone Historic Market Size by Country
8.1.1 Latin America Oxycodone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oxycodone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oxycodone Sales in Value by Country (2018-2023)
8.2 Latin America Oxycodone Forecasted Market Size by Country
8.2.1 Latin America Oxycodone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oxycodone Sales in Value by Country (2024-2029)
9 Middle East and Africa Oxycodone by Country
9.1 Middle East and Africa Oxycodone Historic Market Size by Country
9.1.1 Middle East and Africa Oxycodone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oxycodone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oxycodone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oxycodone Forecasted Market Size by Country
9.2.1 Middle East and Africa Oxycodone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oxycodone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information
10.1.2 Johnson & Johnson Introduction and Business Overview
10.1.3 Johnson & Johnson Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Johnson & Johnson Oxycodone Products Offered
10.1.5 Johnson & Johnson Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Oxycodone Products Offered
10.2.5 Sanofi Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Oxycodone Products Offered
10.3.5 Pfizer Recent Development
10.4 Purdue Pharma
10.4.1 Purdue Pharma Company Information
10.4.2 Purdue Pharma Introduction and Business Overview
10.4.3 Purdue Pharma Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Purdue Pharma Oxycodone Products Offered
10.4.5 Purdue Pharma Recent Development
10.5 Endo International
10.5.1 Endo International Company Information
10.5.2 Endo International Introduction and Business Overview
10.5.3 Endo International Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Endo International Oxycodone Products Offered
10.5.5 Endo International Recent Development
10.6 Teva Pharmaceuticals
10.6.1 Teva Pharmaceuticals Company Information
10.6.2 Teva Pharmaceuticals Introduction and Business Overview
10.6.3 Teva Pharmaceuticals Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceuticals Oxycodone Products Offered
10.6.5 Teva Pharmaceuticals Recent Development
10.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
10.7.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Company Information
10.7.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Introduction and Business Overview
10.7.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Products Offered
10.7.5 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Recent Development
10.8 Mallinckrodt
10.8.1 Mallinckrodt Company Information
10.8.2 Mallinckrodt Introduction and Business Overview
10.8.3 Mallinckrodt Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mallinckrodt Oxycodone Products Offered
10.8.5 Mallinckrodt Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Oxycodone Products Offered
10.9.5 Mylan Recent Development
10.10 Sun Pharmaceutical (Chattem Chemicals)
10.10.1 Sun Pharmaceutical (Chattem Chemicals) Company Information
10.10.2 Sun Pharmaceutical (Chattem Chemicals) Introduction and Business Overview
10.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Products Offered
10.10.5 Sun Pharmaceutical (Chattem Chemicals) Recent Development
10.11 Impax Laboratories
10.11.1 Impax Laboratories Company Information
10.11.2 Impax Laboratories Introduction and Business Overview
10.11.3 Impax Laboratories Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Impax Laboratories Oxycodone Products Offered
10.11.5 Impax Laboratories Recent Development
10.12 Indivior
10.12.1 Indivior Company Information
10.12.2 Indivior Introduction and Business Overview
10.12.3 Indivior Oxycodone Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Indivior Oxycodone Products Offered
10.12.5 Indivior Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oxycodone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oxycodone Industrial Chain Analysis
11.4 Oxycodone Market Dynamics
11.4.1 Oxycodone Industry Trends
11.4.2 Oxycodone Market Drivers
11.4.3 Oxycodone Market Challenges
11.4.4 Oxycodone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oxycodone Distributors
12.3 Oxycodone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
